in ,

Artificial Intelligence (AI) in Drug Discovery Market to Grow at a Highly Phenomenal CAGR of 37.67% by 2027, Estimates DelveInsight


Las Vega (Nevada), United States – The Artificial Intelligence (AI) in Drug Discovery Market is expected to grow in the coming years owing to the rising prevalence of various diseases worldwide, which have necessitated the need for faster development of highly safe and efficacious drugs. Moreover, the realization of the advantages of AI in the pharmaceutical sector motivates pharma companies and institutes to invest further in drug research and development.

Furthermore, the extensive partnerships and collaborations between public and private entities at national and international levels are further expected to boost AI in the drug discovery market. The leading companies in the Artificial Intelligence in Drug Discovery Market include IBM Corporation, NuMedii Inc, Deep Genomics, NVIDIA Corporation., Atomwise Inc., Cloud Pharmaceuticals, Inc, Alphabet Inc (Deep Mind), Insilico Medicine, BenevolentAI, Exscientia, Cyclica., Valo Health Owkin, Verge Genomics, BioSymetics., BeiGene and others.

DelveInsight’s “Artificial Intelligence in Drug Discovery Market Forecast 2027” research report provides the current and forecasted Artificial Intelligence in Drug Discovery market size, share, and trends analysis for the next five years, upcoming innovations in the segment, and major market drivers & barriers. The report also covers the key competitors, emerging products, and technologies in the domain.

Artificial Intelligence in Drug Discovery: Overview
Artificial intelligence (AI) in drug discovery is the utilization of advanced computing techniques such as machine learning, artificial neural networks, and natural language processing to process large amounts of data to help with the target, lead identification, and other required inputs for drug discovery and development. Artificial intelligence (AI) presents immense potential to alter the drug discovery process, and the segment, over the past few, has registered significant growth. Globally, more than 150 companies are working in Artificial Intelligence in the Drug Discovery market. Some of the companies have raised funds and progressed molecules into clinical trials.

Artificial Intelligence in Drug Discovery Market – Key Takeaways
– As per DelveInsight’s assessment, in the type segment of AI in the drug discovery market, the de novo drug design category is estimated to hold a prominent market share in the coming years. This can be attributed to the advantages associated with AI in de novo drug design and optimization.
– The Artificial Intelligence in Drug Discovery Market is expected to grow immensely owing to the rising prevalence of various diseases across the globe, which has necessitated the need for faster development of highly safe and efficacious drugs. The growth in investment in the drug research and development segment and extensive partnerships and collaborations between public and private entities and both national and international levels are also expected to propel the market growth.
– Some of the key factors, such as the knowledge gaps between biologists, chemists, and AI scientists, as well as limitations of traditional machine learning tools in handling the volume of data generated in the pharmaceutical field, may hamper AI in the drug discovery market growth.
– Among all the regions, North America is estimated to hold the largest revenue share in the global AI in drug discovery market during the forecast period.
– Major factors contributing to the higher growth in the North American regions are – the presence of a large patient population associated with various diseases, including cancers, and neurological disorders, which in turn drive the demand for various drugs with minimal side effects. Moreover, the extensive focus on clinical research and the presence of key players in the region from both the pharmaceutical and technology domains.

Artificial Intelligence in Drug Discovery Market – Key Developments and Breakthroughs
Over the years, Artificial Intelligence in the Drug Discovery market has evolved significantly owing to the active participation of HealthTech and MedTech companies and technological advancements in the domain. Some of the major advancements in recent years in the Artificial Intelligence in Drug Discovery market are –
– On December 6, 2022, Ultromics announced that its Ultromics’ EchoGo® Heart Failure, an AI solution for echocardiography with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug Administration (FDA) clearance. The news puts EchoGo® Heart Failure in the 7% of devices that have gone on to obtain full marketing authorization after being awarded FDA breakthrough status.
– In January 2022, Sanofi entered into a research collaboration with Exscientia, which uses artificial intelligence to discover new drug candidates that could be worth up to USD 5.2 billion for the latter company.
– In December 2021, Insilico Medicine announced the start of the world’s first Phase I clinical trial of a drug developed from scratch using AI. Its end-to-end platform applies AI to biology for target discovery and to chemistry for drug design.
– In November 2021, Alphabet Inc. announced the launch of a new company- Isomorphic Laboratories, which will leverage AI for drug discovery.

As per DelveInsight, the ongoing clinical & commercial development activities and research in the domain will contribute immensely to the Artificial Intelligence in Drug Discovery Market growth in the coming years.

Key Companies in the Artificial Intelligence in Drug Discovery Market
The leading MedTech giants in the Artificial Intelligence in Drug Discovery market include IBM Corporation, NuMedii Inc, Deep Genomics, NVIDIA Corporation., Atomwise Inc., Cloud Pharmaceuticals, Inc, Alphabet Inc (Deep Mind), Insilico Medicine, BenevolentAI, Exscientia, Cyclica., Valo Health Owkin, Verge Genomics, BioSymetics., and BeiGene others.

As per DelveInsight, due to the high growth rate and positive return, several new players are expected to enter the Artificial Intelligence in Drug Discovery market in the coming years. The entry of new players and the launch of emerging products will immensely drive market growth.

Learn how new players’ entries will transform the market dynamics in the coming years @ Artificial Intelligence in Drug Discovery Market Trends and Evolving Competitive Landscape

Scope of the Artificial Intelligence in Drug Discovery Market Report:
– Study Period – 2019-2027
– Geography Covered – Global (North America, Europe, Asia-Pacific, and Rest of the World)
– Artificial Intelligence in Drug Discovery Market By Type – De Novo Drugs Design And Optimization, Preclinical Testing, And Others
– Artificial Intelligence in Drug Discovery Market By Application – Oncology, Cardiovascular, Infection Disease, and Other
– Artificial Intelligence in Drug Discovery Market By End User – Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others
– Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

DelveInsights’ Remark: The “Artificial Intelligence in Drug Discovery Market” is anticipated to grow at a significant CAGR of 37.67% till 2027. North America is expected to dominate Artificial Intelligence in Drug Discovery Market.

Table of Content

1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Artificial Intelligence (AI) in Drug Discovery Market Key factors analysis
5. Artificial Intelligence (AI) in Drug Discovery Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Artificial Intelligence (AI) in Drug Discovery Market
7. Artificial Intelligence (AI) in Drug Discovery Market Layout
8. Artificial Intelligence (AI) in Drug Discovery Global Company Share Analysis
9. Artificial Intelligence (AI) in Drug Discovery Product Profiles and Key Companies
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Reach out to us to get a more detailed overview of the market @ Artificial Intelligence in Drug Discovery Market Forecast and Outlook 2027

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us
Shruti Thakur
Manager (Marketing & Branding)
[email protected]
+1(919)321-6187
www.delveinsight.com



Source link

What do you think?

$SWISF CEO Explains How LinkedIn Hacks Occur And How Sekur Private Data Helps Protect Against Hacks

Artists from Mexico grace Ann Arbor water plant with new public art mural